Significant Ownership of Bleichroeder LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bleichroeder LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Andrew Gundlach - Chairman and CEO
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bleichroeder LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Bleichroeder LP
Significant Ownership of Bleichroeder LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| First Eagle Real Estate Debt Fund | Class I Common Shares of Beneficial Interest, $0.001 par value | 99% | 1,367,807 | +86% | Bleichroeder LP | 06 Aug 2025 | |||
| LIQT | LiqTech International, Inc. | Common Stock, $0.001 par value | 34% | $1,304,718 | 3,182,239 | 0% | Bleichroeder LP | 26 Mar 2025 | |
| SCND | Scientific Industries, Inc. | Common Stock, $0.05 par value | 21% | $2,009,119 | -$185,000 | 2,715,026 | -8.4% | Bleichroeder LP | 30 Sep 2025 |
| LIQT | LiqTech International, Inc. | Common Stock, $0.001 par value | 21% | $15,072,103 | +$8,103,000 | 6,882,239 | +116% | Bleichroeder LP | 05 Jun 2026 |
| DUOT | Duos Technologies Group, Inc. | Common Shares | 20% | $9,631,578 | 1,504,934 | Bleichroeder LP | 19 Mar 2025 | ||
| INVE | Identiv, Inc. (INVE) | Common Stock, $0.001 par value | 20% | $16,305,879 | 5,079,713 | Bleichroeder LP | 19 Mar 2025 | ||
| IVAC | Intevac, Inc. | Common Shares | 19% | $20,130,897 | 5,039,023 | Bleichroeder LP | 19 Mar 2025 | ||
| MDXH | MDxHealth SA | Ordinary Shares | 15% | $24,220,525 | 7,429,609 | +0.69% | Bleichroeder LP | 19 Mar 2025 | |
| IDN | Intellicheck, Inc. | Common Shares | 11% | $5,391,316 | 2,073,583 | Bleichroeder LP | 19 Mar 2025 | ||
| CUE | Cue Biopharma, Inc. | Common Stock, par value $0.001 per share | 10% | $5,269,789 | 6,127,662 | 0% | Bleichroeder LP | 19 Mar 2025 | |
| BRFH | Barfresh Food Group Inc. | Common Shares | 10% | $4,670,617 | +$693,050 | 1,633,083 | +17% | Bleichroeder LP | 31 Mar 2026 |
| COCHW | ENVOY MEDICAL, INC. | Class A Common Shares | 10% | $520,510 | 7,839,000 | Bleichroeder LP | 31 Mar 2026 | ||
| EVOK | Evoke Pharma, Inc. | Common Shares | 10% | $63,223 | 158,058 | -81% | Bleichroeder LP | 24 Mar 2025 | |
| CRIS | Curis Inc | Common Shares | 9.9% | $1,636,346 | 1,035,662 | Bleichroeder LP | 31 Mar 2025 | ||
| FLNT | Fluent, Inc. | Common Shares | 9.6% | $6,342,855 | 2,857,142 | Bleichroeder LP | 30 Sep 2025 | ||
| DTIL | PRECISION BIOSCIENCES INC | Common Shares | 8.2% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES ORD | Common Shares | 8% | $2,800,000 | 4,000,000 | Bleichroeder LP | 30 Jun 2025 | ||
| GUER | Guerrilla RF, Inc. | Common Shares | 7.7% | $800,000 | 800,000 | Bleichroeder LP | 19 Mar 2025 | ||
| ERNA | ERNEXA THERAPEUTICS INC. | Common Shares | 6.9% | $14,400 | 80,000 | Bleichroeder LP | 31 Mar 2026 | ||
| CMPO | CompoSecure, Inc. | Class A Common Stock, $0.0001 par value per share | 4.7% | $43,808,462 | 3,897,550 | Bleichroeder LP | 30 Sep 2024 | ||
| CLRB | Cellectar Biosciences, Inc. | Common Shares | 4.6% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| SMTK | SmartKem, Inc. | Common Shares | 4.1% | $389,199 | 231,666 | 0% | Bleichroeder LP | 30 Sep 2025 | |
| APTO | Aptose Biosciences Inc. | Common Shares | 1.6% | $4,583 | -$13,350 | 41,666 | -74% | Bleichroeder LP | 30 Jun 2025 |
Schedules 13D/G Reported by Bleichroeder LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.